Thymosin Alpha-1 (Tα1)
Immune-system peptide. Approved in many countries for hepatitis B/C and as adjunct to chemotherapy. Used here for chronic immune issues and post-illness recovery.
Thymosin Alpha-1 (Tα1): Immune-system peptide. Approved in many countries for hepatitis B/C and as adjunct to chemotherapy. Used here for chronic immune issues and post-illness recovery. Thymosin Alpha-1 is the immune-system peptide.
Thymosin Alpha-1 is the immune-system peptide. Approved in many countries for hepatitis and as adjunct to chemotherapy. Used here for chronic immune issues, post-illness recovery, or as a winter immune-support tool.
Not FDA approved in the U.S. Has orphan drug status for some indications. Approved in 35+ countries (sold as Zadaxin) for hepatitis B/C and chemotherapy adjunct.
Its nomination was withdrawn in 2024, and FDA's advisory committee voted against including it in December 2024. It is not on the 503A list and is not scheduled for another review.
Yes outside the U.S., prescribed by hepatology / oncology providers in countries where Zadaxin is approved.
Who it's for
- →Users with chronic immune issues
- →Post-illness recovery support
- →Cancer / hepatitis-adjunct context under medical care
What to expect
- Week 1
Subtle. Energy / immune-feel often shifts first.
- Week 4
Chronic-illness markers improve in clinical contexts.
- Week 8
Plateau. Cycle off.
Looking at Thymosin Alpha-1 (Tα1)? Your next 3 steps
- 1Work out your syringe units
Vial size + BAC water turns into the exact units to draw for Thymosin Alpha-1 (Tα1).
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account gets you Coach questions every day, free; membership saves your stack and makes the Coach stack-aware.
Create free account →
How it works (mechanism)
28-amino-acid peptide derived from prothymosin alpha. Activates Toll-like receptors (both TLR2 and TLR9) on dendritic cells, broadly enhancing T-cell-mediated immune responses without direct antigen specificity.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Active immunosuppression therapy (talk to provider)
- ⚠Pregnancy / nursing
Bloodwork to monitor
- • CBC if running long term
Common mistakes
- • Treating it like an acute immune fix
- • Skipping cycle breaks
- • Underdosing for chronic conditions
What it actually is
Thymosin alpha-1 is a 28-amino-acid peptide originally isolated from the thymus, the gland that trains your immune system's T cells. Unlike most peptides here it is an approved medicine in a large number of countries — though not the United States — for hepatitis B and C and as an adjunct in cancer treatment and vaccination. It has a substantial clinical literature: 35 randomised trials and 49 indexed human-trial records.
It acts largely through Toll-like receptor signalling on dendritic cells, the cells that present threats to the rest of the immune system. The effect is described as modulating rather than stimulating: it appears to improve T cell maturation and function and to shift immune responses toward a more effective pattern, rather than simply turning the immune system up. That distinction matters, because a general immune stimulant would be a bad idea in autoimmune disease, and this one is used in contexts where the immune response is failing rather than overactive.
Forms, and which is which
Approved in many countries for hepatitis B and C and as an immune adjunct. Manufacturer product with assured identity.
Verdict: The reference form where it is available.
Research-chemical or compounded supply, since there is no US approval. Identity unverified in the research-chemical case.
Verdict: The common route in the US, with the usual caveats.
Whole-gland extracts rather than a defined single peptide, used mainly in Russian and Eastern European practice.
Verdict: A mixture rather than a molecule — different proposition.
A 28-amino-acid peptide is not absorbed intact from the gut.
Verdict: Not plausible by the route claimed.
What it is claimed to do, graded
The basis for approval across many countries, supported by randomised trials and meta-analyses.
Studied in dialysis and elderly populations with reasonable randomised support.
Used alongside chemotherapy in several countries, with trial support that is real and mostly not from large Western programmes.
Studied with mixed results. Interesting mechanistically, not established.
Most non-clinical use is this, and it has not been studied. An immune modulator in someone whose immune system is working normally has no demonstrated benefit.
Grades describe how much human evidence exists for that specific claim, not whether it will work for you or whether it is safe.
Pros and cons
- • Genuinely approved in many countries, on real trial evidence
- • A large clinical literature by the standards of this catalog — 35 randomised trials
- • Very well tolerated across decades of clinical use
- • Modulates rather than simply stimulates, which is the safer profile
- • Not FDA approved, so US supply is compounded or research-chemical
- • The evidence is in specific patient populations, not healthy adults
- • Immune modulation is not obviously desirable if your immune system is already functioning
- • Expensive relative to most peptides
- • Autoimmune disease is a genuine caution, not a formality
When to stop
- • Any autoimmune symptom appearing or worsening: joint pain, rashes, unexplained fatigue
- • Injection-site reaction that spreads
- • You have started immunosuppressant therapy for anything
- • No measurable change in the marker you started it for
Interactions
Working against the intended effect of the other drug. This matters most in transplant patients and treated autoimmune disease.
Modulating immune function where the immune system is already attacking the body is unstudied and could go either way.
Studied as a vaccine adjunct in immunocompromised populations, which is one of its better-supported uses.
Used as an adjunct in several countries, and that should be an oncologist's decision rather than an addition made independently.
Opposing effects on immune function.
Is this for you?
- • People with a specific immune-related diagnosis working with a clinician
- • Anyone in a country where it is an approved, prescribed medicine
- • You have an autoimmune disease
- • You are on immunosuppressants or post-transplant
- • You are pregnant or nursing
- • Your immune system is working normally — that population has not been studied
The one number
Sources for the claims above
- Comprehensive review of the literature
- Drug profile
- Thymosin alpha-1 and ageing
Drug & supplement interactions
- ⚠Immunosuppressants (cyclosporine, tacrolimus, biologics): may counteract Tα1's immune-enhancing effect
- ⚠Vaccination: may enhance vaccine response
- ⚠Limited published interaction data outside oncology / hepatitis contexts
Community patterns
New to Thymosin Alpha-1 (Tα1)? Grab the starter checklist.
Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.
No spam, and we never sell your email. Just the checklist. Email support@pepdex.co to opt out any time.
Numbers redacted in this preview. Members get the full answer, on their own stack.
Ask the Coach anything about Thymosin Alpha-1 (Tα1) or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Unlock the full Coach, from $4.99/week →Frequently asked
What is Thymosin Alpha-1 (Tα1)?+
Is Thymosin Alpha-1 (Tα1) FDA approved?+
Is Thymosin Alpha-1 (Tα1) legal?+
Is Thymosin Alpha-1 (Tα1) banned by WADA?+
Are you still natty after taking Thymosin Alpha-1 (Tα1)?+
Do doctors prescribe Thymosin Alpha-1 (Tα1)?+
What's the typical dose of Thymosin Alpha-1 (Tα1)?+
What are the side effects of Thymosin Alpha-1 (Tα1)?+
How long until Thymosin Alpha-1 (Tα1) starts working?+
What can you stack with Thymosin Alpha-1 (Tα1)?+
Where do people get Thymosin Alpha-1 (Tα1)?+
Thymosin Alpha-1 (Tα1) vs LL-37, which is better?+
Common questions about Thymosin Alpha-1 (Tα1)
Head-to-head with Thymosin Alpha-1 (Tα1)
Tracked alongside Thymosin Alpha-1 (Tα1)
Same goal, different aisle — each graded on its own evidence in the Pepdex catalog.
More in Immune
A germ-fighter your immune system already makes on its own. It's a cathelicidin-derived antimicrobial peptide used for chronic infections and biofilm-associated issues.
Endogenous 28-amino-acid neuropeptide. Modulates immune function and inflammation. Used in CIRS (chronic inflammatory response syndrome) protocols and biotoxin exposure recovery, popularized by Dr. Ritchie Shoemaker.
Calms inflammation in the gut and skin. A tripeptide fragment of alpha-MSH used for gut conditions and skin inflammation.
Used to rebuild a weakened immune system, mainly in older or post-illness patients. A polypeptide complex extracted from calf thymus and distinct from Thymosin Alpha-1, used in Russian and Eastern European clinical practice for immune restoration in elderly patients and post-illness recovery.